Oral Answers to Questions Debate

Full Debate: Read Full Debate
Department: Cabinet Office

Oral Answers to Questions

Tonia Antoniazzi Excerpts
Wednesday 19th June 2019

(4 years, 10 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Theresa May Portrait The Prime Minister
- Hansard - - - Excerpts

My hon. Friend has raised an important issue. I am very pleased to see the announcement today by Jersey, Guernsey and the Isle of Man. We continue to work with overseas territories to ensure that they follow those standards and open their books so that people can see who actually owns companies.

Tonia Antoniazzi Portrait Tonia Antoniazzi (Gower) (Lab)
- Hansard - -

Q2. Following my visit to the Netherlands two weeks ago with Emma Appleby, I have witnessed at first hand the incompetence of the Home Office and the Department of Health and Social Care in delivering medical cannabis with THC, not just CBD, for children with severe epilepsy. History was made exactly one year ago today when Alfie Dingley received the licence for his medication and the Prime Minister looked Hannah Deacon, Alfie’s mum, in the eye and promised to right this wrong. Today, will the Prime Minister commit to making it part of her legacy to deliver on her promise not just to Alfie, but to the many other children who are still suffering?

Theresa May Portrait The Prime Minister
- Hansard - - - Excerpts

The hon. Lady is absolutely right that we looked at the whole issue of medical cannabis. That is why we changed the approach that was taken. Obviously, individual cases are desperately difficult, and I think that everybody across the House feels with the families and friends of those who are affected. We have ensured that the law has changed and that specialist doctors can prescribe cannabis-based products for medicinal use, where there is clinical evidence of benefit. I think that was the right thing to do. My right hon. Friend the Secretary of State for Health and Social Care has heard the testimony of families about the barriers they appear to have faced and has asked NHS England to undertake a rapid re-evaluation and to address any system barriers to clinically approving the prescribing.